By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Fangzhou Inc. (6086.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$3.73
-$0.12
-3.12%
Last Update: 29 Aug 2025, 08:08
$4.96B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$1.60 - $8.18
52 Week Range

6086.HK Stock Price Chart

Explore Fangzhou Inc. interactive price chart. Choose custom timeframes to analyze 6086.HK price movements and trends.

6086.HK Company Profile

Discover essential business fundamentals and corporate details for Fangzhou Inc. (6086.HK) to support your stock research and investment decisions.

Sector

Consumer Cyclical

Industry

Drug Manufacturers - General

IPO Date

Employees

488.00

CEO

Fangmin Xie

Description

Fangzhou Inc. provides online chronic disease management services in China. The company provides services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It offers H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform, as well as operates hospitals and offline pharmacies. The company was founded in 2015 and is based in Guangzhou, China.

6086.HK Financial Timeline

Browse a chronological timeline of Fangzhou Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

6086.HK Stock Performance

Access detailed 6086.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run